MEIP


MEI Pharma Inc (MEIP) Poised To Move Higher; Here’s Why

When investing in biotech companies, I try to find undervalued companies with low-risk upcoming catalysts. For example, several months ago when Medivation (NASDAQ:MDVN) …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Appoints Dr. Christine White as Chairman of the Board

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the appointment of Christine White, …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced positive results from a …

MEI Pharma Inc (MEIP): ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML

I wrote an article last week detailing why investors should buy MEI Pharma Inc (NASDAQ:MEIP) before the American Society of Hematology (ASH) meeting on Decemeber …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Highlights New Data from Phase II Clinical Studies of Pracinostat in Acute Myeloid Leukemia and Myelodysplastic Syndrome

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the publication of new …

Cowen Offers Commentary on Two Biotech Stocks: MEI Pharma Inc (MEIP), Genocea Biosciences Inc (GNCA)

Cowen analysts came out today with an optimistic view on the oncology company MEI Pharma Inc (NASDAQ:MEIP) and vaccine development company Genocea Biosciences Inc (NASDAQ:GNCA), as the iShares Nasdaq …

Looking Ahead of Wall Street: MEI Pharma Inc (MEIP), Sarepta Therapeutics Inc (SRPT), Novavax, Inc. (NVAX), XOMA Corp (XOMA)

Now that Wall Street is in the second half of the year, analysts are anticipating updates and announcements about pipeline drugs from biopharmaceutical …

Cantor Reiterates Buy on MEI Pharma Inc (MEIP) Following 2Q:15 Update; Sees 281 Upside for the Stock

In a research report published Wednesday, Cantor analyst Daniel Brims reiterated a Buy rating on shares of MEI Pharma Inc (NASDAQ:MEIP), with a price …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Reports Fiscal Year 2015 Results

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced results for its fiscal year …

Wedbush Keeps MEI Pharma Inc at Neutral Following Updated Pracinostat Phase 2 Data

In a research report released Friday, Wedbush analyst David Nierengarten reiterated a Neutral rating on MEI Pharma Inc (NASDAQ:MEIP) with a $3 price target, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts